Dual-Targeting Breakthrough: Clinical Trials Begin for Innovative Hidradenitis Suppurativa Antibody Therapy
Executive Overview For individuals living with moderate-to-severe hidradenitis suppurativa (HS), the search for enduring relief is often a…
